Ecolab Inc. Q2 FY2025 earnings call

• The team delivered a strong quarter consistent with guidance, with organic sales growth 3% led by value pricing, One Ecolab strategy, and growth engines. • Value pricing increased to 2% in Q2, with a trade surcharge implemented in the US, expecting total pricing to strengthen to ~3% in Q3 and Q4. • Core segments like Institutional & Specialty drove share gains despite exiting noncore low-margin businesses, and Global Water performed well with food and beverage driving growth. • Growth engines: Pest Elimination shifted to pest intelligence with pilot success, Life Sciences had mid-single digits growth with biopharma strong, Global High-Tech grew rapidly, and Ecolab Digital accelerated sales growth. • SG&A leverage driven by One Ecolab, with savings from cross-sell opportunities and AI automation.

Ecolab delivered a strong quarter with organic sales growing 3%. The paper and basic industries, representing 15% of sales, had end market demand challenges, but the remaining 85% of the business grew organic sales 4% and operating income by 18%. Growth engines like Pest Elimination (organic sales growth accelerated to 6%), Life Sciences (mid-single digits growth, biopharma strong), Global High-Tech (sales up over 30%), and Ecolab Digital (sales growth to nearly 30% with annualized run rate of $380 million) contributed significantly. These growth engines collectively make up nearly $3 billion in annual sales and grew double digits in the second quarter.

• Management expects 12%-15% adjusted EPS growth for the second half of 2025 and beyond. • Full-year 2025 operating income margin is expected to reach 18%, with a goal of 20% OI margin by 2027. • Confident in future performance due to strong business portfolio, growth engines, and innovation pipeline.

• Unpredictable global operating environment poses risks. • Tariffs and trade dynamics could impact costs and pricing. • Potential capacity constraints in some businesses like Life Sciences water purification. • Cyclicality in certain end markets like paper and basic industries may pose challenges.

Q: Some folks thought Ecolab might raise guidance, but what's the outlook?

A: It's a combination of conservatism and investing in growth businesses, with a commitment to 12%-15% adjusted EPS growth for the second half and beyond, driven by good momentum in 85% of the business and strong growth engines.

Q: Talk about pricing, especially the U.S. trade surcharge?

A: Value pricing is at 2% in Q2, with the U.S. trade surcharge implemented, expecting pricing to move closer to 3% in Q3 and Q4, backed by value delivery to customers.

Q: Pest Elimination's shift to pest intelligence, any headwinds?

A: The shift to pest intelligence requires investments and a significant transformation, but it's expected to lead to long-term growth, better margins, and 99% pest-free environments for customers.

Q: Delivered product cost and second half outlook?

A: Commodity inflation is expected to be low to mid-single digits, with supply chain efficiencies helping to keep delivered product cost favorable, and gross margins up 100 basis points in Q2.

Q: Inorganic growth pipeline?

A: Ecolab is in a strong position with a fortress balance sheet, low leverage, and focused on investing in Water, High-Tech, Life Science, and digital technology areas, with a disciplined approach to capital deployment.